S-2512

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameS-2512
Drug Alias NameS-2512 backups (Galilaeus)S-2512
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionDNA topoisomerase I inhibitorsDNA intercalatorsTopoisomerase II inhibitors
TargetsTopoisomerase IIDNADNA topoisomerase I
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanyFinland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGalilaeus Oy
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGalilaeus OyHeidelberg Pharma AG
Active IndicationsN/A
Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A
Related LinksN/A